• Like
 MediPoint: In-Vitro Colorectal Cancer Screening Tests:Industry Forecast Report
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

MediPoint: In-Vitro Colorectal Cancer Screening Tests:Industry Forecast Report

  • 57 views
Published

MediPoint: In-Vitro Colorectal Cancer Screening Tests - Global Analysis and Market …

MediPoint: In-Vitro Colorectal Cancer Screening Tests - Global Analysis and Market Forecasts@http://www.researchmoz.us/medipoint-in-vitro-colorectal-cancer-screening-tests-global-analysis-and-market-forecasts-report.html

Published in Health & Medicine , Business
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
57
On SlideShare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. MediPoint: In-Vitro Colorectal Cancer Screening Tests - Global Analysis and Market Forecasts Colorectal cancer (CRC) is the third most commonly diagnosed cancer, and the second most common cause of mortality amongst cancer patients. Prognosis is directly related to early diagnosis, with survival rates dramatically improved by early diagnosis and treatment. Thanks to the introduction of CRC screening programs, mortality in the developed countries is falling; however incidence continues to rise as a result of diet and increasingly sedentary lifestyles. While historically, colorectal cancer incidence in the developing world is low, in recent years, disease diagnosis rates have dramatically increased, as a result of changing lifestyles, awareness and improved access to medical services. CRC screening can improve survival rates, and reduce the overall cost of patient treatment. Questions Answered in this Report Colorectal cancer can be caused by somatic mutations as well as inherited mutations. These mutations lead to changes in the colon, that can be detected by detection of bleeding. But many of these mutations can be also be detected by genetic and other tests. How quickly will new gene tests be adopted by the CRC screening market?? What are the key differences in CRC screening carried out in different countries, and how will these differences affect adoption of new screening tests? Existing CRC screening is based on inexpensive, but inaccurate stool analysis tests, or expensive but accurate endoscopies. The first DNA screening tests are expected to come to market in 2014, from Exact Sciences and EpiGenomics. Which new DNA-based screening test will win out ? In-vitro CRC screening is a fast evolving technological area. How will change in technology affect sales of existing CRC screening tests? Who are the new players in CRC screening? How will patient attitudes affect the In-vitro CRC screening test market? table Of Contents 1 Table Of Contents 1.1 List Of Tables 1.2 List Of Figures 2 Introduction 2.1 Catalyst 2.2 Related Reports 3 Disease Overview 3.1 Colorectal Cancer 3.2 Anatomy And Physiology 3.3 Pathophysiology 3.3.1 Histology 3.3.2 Genetic Basis 3.3.3 Etiology Of Crc MediPoint: In-Vitro Colorectal Cancer Screening Tests - Global Analysis and Market Forecasts
  • 2. 3.4 Clinical Presentation 3.4.1 Symptoms 3.4.2 Screening Overview 3.4.3 Status Of National Crc Screening Programs 3.4.4 Diagnosis Overview 3.4.5 Staging Colorectal Cancer 3.5 Clinical Outcomes 3.5.1 Treatment Paradigms 3.5.2 Treatment Options Overview 3.6 Epidemiology 3.6.1 Global And Historical Trends 3.7 Epidemiology Forecast (2012–2018) 3.7.1 Total Incident Cases Of Colorectal Cancer 3.8 Economic Impact 3.8.1 Individual Costs 4 Competitive Assessment 4.1 Overview 4.2 Fecal Occult Blood Tests 4.2.1 Guaiac Fecal Occult Blood Stool Tests 4.2.2 Lateral Flow Immuno-fecal Occult Blood Tests 4.2.3 Readers 4.2.4 Immuno-fob Test Elisa 4.2.5 Immuno-fob Agglutination Tests 4.3 Crc Dna Screening Tests 4.3.1 Panel Dna Tests 4.3.2 Methylated Gene Testing 4.4 Other Biomarker Tests 4.4.1 Overview 4.4.2 Tumor M2-pk Stool Test/2-in-1 Quick Test 4.4.3 Transferrin Assays 5 Unmet Needs 5.1 False Negative Results 5.2 False Positive Results 5.3 Sample Type 5.4 Screening Compliance 5.5 Alternative To Colonoscopy 5.6 Accurate Early Staging Of Colorectal Cancer 5.7 Screening Test Alternatives 5.8 Automation MediPoint: In-Vitro Colorectal Cancer Screening Tests - Global Analysis and Market Forecasts
  • 3. 6 Pipeline Products 6.1 Overview 6.2 Pipeline By Phases In Development 6.3 Pipeline Product Profiles 6.3.1 Bst1 Crc Assay 6.3.2 Cologic 6.3.3 Cologuard 6.3.4 Colon Cancer Bec Test 6.3.5 Colon Marcare Plex 6.3.6 Colox 6.3.7 Crc Bacterial Signature Assay 6.3.8 Crc Breath Test 6.3.9 Epi Procolon 6.3.10 Exiqon Microrna Test 6.3.11 Gemini Crc Biomarker Assay 6.3.12 Genomictree Methylated Dna Test 6.3.13 Measure Fecal Occult Blood Test 6.3.14 Metabiomics Crc Test 6.3.15 Mir-21 Test 6.3.16 Oncolite Cr 6.3.17 Panc-dx 7 Industry Overview 7.1 Colorectal Cancer Screening Test Trends 7.1.1 Us 7.1.2 5eu 7.1.3 Apac 7.1.4 South America (brazil) 7.2 Market Access 7.3 Reimbursement Trends 7.3.1 Us 7.3.2 5eu 7.3.3 Apac 7.3.4 South America (brazil) 7.4 Regulatory Issues And Recalls 7.4.1 Us 7.4.2 5eu 7.4.3 Recalls 7.5 Mergers And Acquisitions MediPoint: In-Vitro Colorectal Cancer Screening Tests - Global Analysis and Market Forecasts
  • 4. 8 Current And Future Players 8.1 Overview 8.2 Trends In Corporate Strategy 8.3 Company Profiles 8.3.1 Abbott Molecular 8.3.2 Alere 8.3.3 Beckman Coulter 8.3.4 Biomarcare Technologies 8.3.5 Companion Dx 8.3.6 Eiken Chemical 8.3.7 Epigenomics 8.3.8 Exact Sciences 8.3.9 Exiqon 8.3.10 Fujirebio (miraca Holdings) 8.3.11 Genenews 8.3.12 Genomictree 8.3.13 Immunostics 8.3.14 Kyowa Medex 8.3.15 Mdx Health (was Oncomethylome) 8.3.16 Merck Millipore 8.3.17 Metabiomics 8.3.18 Mode Diagnostics 8.3.19 Oncocyte (bio Time) 8.3.20 Quest Diagnostics 8.3.21 R-biopharm 8.3.22 Randox Laboratories 8.3.23 Schebo Biotech 8.3.24 Scimarket Technologies 8.3.25 Siemens Healthcare 8.3.26 Signature Diagnostics 8.3.27 Sysmex 8.3.28 Veda Lab 9 Market Drivers, Opportunities And Barriers 9.1 Market Drivers 9.1.1 Uptake Of Pipeline Biomarker Tests 9.1.2 Increasing Incidence Of Colorectal Cancer And Improvements In Treatment 9.1.3 Patient Reluctance To Colonoscopies In Opportunistic Crc Screening 9.1.4 Increasing Volume Of Fob Tests In Emerging Markets 9.1.5 Increased Pressure On Endoscopy Services 9.2 Opportunities 9.2.1 Blood Tests MediPoint: In-Vitro Colorectal Cancer Screening Tests - Global Analysis and Market Forecasts
  • 5. 9.2.2 Increasing Crc Screening Compliance 9.2.3 Integration Of Crc Screening Tests With Prognostic Tests And Other Screening Programs 9.2.4 Emerging Markets 9.3 Market Barriers 9.3.1 Cultural And Social Resistance To Stool Tests 9.3.2 Crc Screening Awareness And Education 9.3.3 Reimbursement 9.3.4 Local Requirements 9.3.5 Test Complexity 9.3.6 Patenting Issues 10 Country Outlooks & Forecasts 10.1 10 Major Markets Overview 10.2 Us 10.2.1 Us Market Analysis 10.3 France 10.3.1 France Market Analysis 10.4 Germany 10.4.1 Germany Market Analysis 10.5 Italy 10.5.1 Italy Market Analysis 10.6 Spain 10.6.1 Spain Analysis 10.7 Uk 10.7.1 Uk Market Analysis 10.8 Rest Of World 10.8.1 Japan Market Analysis 10.8.2 Brazil Market Analysis 10.8.3 China Market Analysis 10.8.4 India Market Analysis 11 Appendix 11.1 Abbreviations 11.2 Bibliography 11.3 Research Methodology 11.3.1 Coverage 11.3.2 Secondary Research 11.3.3 Forecasting Methodology 11.4 Physicians And Specialists Included In This Study 11.5 Primary Research 11.6 About The Authors MediPoint: In-Vitro Colorectal Cancer Screening Tests - Global Analysis and Market Forecasts
  • 6. 11.6.1 Analysts 11.6.2 Global Head Of Healthcare 11.7 About Globaldata 11.8 Disclaimer ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ MediPoint: In-Vitro Colorectal Cancer Screening Tests - Global Analysis and Market Forecasts